SCN SIGNS NORDIC DISTRIBUTION AGREEMENT

(NGM:SCN)

Scandinavian Clinical Nutrition AB (SCN) has signed an exclusive marketing and distribution agreement for the company’s products in Scandinavia and Finland with Medica Clinical Nord AB, one of the leading distributors in the region.

Medica Nord is one of Scandinavia’s leading distributors of dietary supplements, natural remedies and natural cosmetics, with a budgeted turnover of MSEK 100 in 2009. The company was formed through a merger between four distribution companies with well-established market positions on the local markets in Sweden, Norway and Denmark, and the business is about to be expanded into Finland as well.

“At Medica Nord, our aim is to provide the consumers with well documented, safe and efficient products, and therefore I am very glad that we have reached this agreement with SCN. SCN is a very important partner for us, not only because of their product portfolio, but also since the R&D work that they do with their partners at Karolinska Institutet and other well-renowned institutions helps reinforce the seriousness of the industry as a whole”, says Bengt Johansson, Marketing Director at Medica Nord.

”I am very glad that we have entered into this agreement with Medica Nord. Their extensive international distribution network in combination with local market and marketing knowledge provides a solid foundation for our products in Scandinavia and Finland, and I look forward to seeing the sales figures and our turnover grow during the next few years”, says Danilo Copiz, VP of Sales at SCN.

Under the agreement, Medica Nord will be responsible for all investments related to distribution and marketing. The company already has experience of some of SCN’s products, since they were distributed by the companies that went into the merger, which facilitates the collaboration and enables a quick start for the sales and marketing process.

For more information, please contact:

Danilo Copiz, VP Sales, dc@scnutrition.com, +45 2090 8885

Ulf Söderberg, Chairman of the Board, us@scnutrition.com, +46 708 13 22 81

Scandinavian Clinical Nutrition AB (publ) works in R&D and distribution of clinically tested, scientifically documented products within the field of nutrition (nutraceuticals). Established in 2006, SCN maintains a product portfolio with established trademarks, such as CUUR, Coldizin, Immulina, Membra7 and Ledactin. Core competence and strategic alliances, within both R&D and sales, in combination with innovative and clinically proven products, create good conditions for profitable growth both in Sweden and internationally. The shares of SCN are traded under the ticker “SCN” on Oslo Axess (www.osloaxess.no) and NGM Equity (www.ngm.se).For more information, please visit www.scnutrition.com.